Alexandra Hornberg
About Alexandra Hornberg
Alexandra Hornberg is an Oncology Product Specialist at Bristol Myers Squibb in Bayern, with an MBA in Gesundheitsmanagement and certification as a Geprüfter Pharmareferent.
Current Role at Bristol Myers Squibb
Alexandra Hornberg is currently serving as an Oncology Product Specialist at Bristol Myers Squibb. She began this role in April 2022 and operates in the Bayern region. In her position, she focuses on providing expertise and specialized knowledge in oncology products, aiding healthcare professionals with the latest developments and information related to cancer treatment.
Previous Experience at Bionorica SE
Before joining Bristol Myers Squibb, Alexandra Hornberg worked at Bionorica SE for three years, from 2019 to 2022. During her tenure, she held the role of Erfahrener Pharmareferent. Her responsibilities included promoting and providing detailed information about pharmaceutical products to healthcare providers, with a particular emphasis on ensuring accurate and beneficial use in medical practices.
MBA in Gesundheitsmanagement from KMU Akademie & Management
Alexandra Hornberg holds an MBA in Gesundheitsmanagement from KMU Akademie & Management. She completed this program in one year, from 2020 to 2021. The program provided her with advanced knowledge and skills in health management, which complement her expertise in the pharmaceutical and oncology sectors.
Certification as Geprüfter Pharmareferent by Pharmig
In addition to her MBA, Alexandra Hornberg is certified as a Geprüfter Pharmareferent by Pharmig. This certification signifies her proficiency and credibility as a pharmaceutical representative, ensuring she meets the industry standards for providing accurate and comprehensive information about pharmaceutical products.
Experience in Oncology Field
Alexandra Hornberg has been working in the oncology field since at least 2019. Her experience spans roles that involve deep engagement with oncology products and treatments, helping bridge the gap between pharmaceutical innovations and clinical applications for better patient outcomes.